Streptococcus pneumoniae (pneumococcus) is a potential cause of bacterial endophthalmitis in humans that can result in ocular morbidity. We sought to identify pneumococcal genes that are differentially expressed during growth in the vitreous humor of the eye in an experimental endophthalmitis model. Microarray analysis was used to identify genes that were differentially expressed when pneumococci replicated in the vitreous of rabbit eyes as compared with bacteria grown in vitro in Todd Hewitt medium. Array results were verified by quantitative real-time PCR analysis of representative genes. Select genes potentially playing a role in virulence during endophthalmitis were deleted, and mutants were tested for reduced eye pathogenesis and altered adhesion to host cells. Array analysis identified 134 genes that were differentially expressed during endophthalmitis; 112 genes demonstrated increased expression during growth in the eye whereas 22 were downregulated. Real-time analysis verified increased expression of neuraminidase A (NanA; SP1693), neuraminidase B (NanB; SP1687) and serine protease (SP1954), and decreased expression of RlrA (SP0461) and choline transporter (SP1861). Mutation of NanA and NanB had no major effect on pathogenesis. Loss of SP1954 led to increased adherence to host cells. S. pneumoniae enhances and represses the expression of a variety of genes during endophthalmitis. While some of these genes reflect changes in metabolic requirements, some appear to play a role in immune evasion and pathogenesis in the eye.

Keywords:
Pneumococcus, Bacterial endophthalmitis, Gene expression analysis, Microarray
1.
Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Corey RP, Miller D: Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol 2004;138:231-236.
2.
Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH: Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001;119:484-489.
3.
Recchia FM, Baumal CR, Sivalingam A, Kleiner R, Duker JS, Vrabec TR: Endophthalmitis after pediatric strabismus surgery. Arch Ophthalmol 2000;118:939-944.
4.
Soriano F, Perez-Trallero E, Pallares R, Meseguer MA, Fleites A, Gene A, Gonzalez A, Linares J, Esteban J, Baquero F, Valdes E, Munoz-Almagro C: Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options. Clin Microbiol Infect 2006;12:519-526.
5.
Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D: Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol 2010;58:497-507.
6.
Kuriyan AE, Weiss KD, Flynn HW Jr, Smiddy WE, Berrocal AM, Albini TA, Miller D: Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol 2014;157:774-780.
7.
Ng EW, Samiy N, Rubins JB, Cousins FV, Ruoff KL, Baker AS, D'Amico DJ: Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis. Retina 1997;17:521-529.
8.
Robertson GT, Ng WL, Foley J, Gilmour R, Winkler ME: Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence. J Bacteriol 2002;184:3508-3520.
9.
Sanders M, Norcross E, Robertson ZM, Moore QC, Fratkin J, Marquart ME: The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis. Invest Ophthalmol Vis Sci 2011;52:865-872.
10.
Sebert ME, Palmer LM, Rosenberg M, Weiser JN: Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun 2002;70:4059-4067.
11.
King SJ, Hippe KR, Gould JM, Bae D, Peterson S, Cline RT, Fasching C, Janoff EN, Weiser JN: Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway. Mol Microbiol 2004;54:159-171.
12.
Dagkessamanskaia A, Moscoso M, Henard V, Guiral S, Overweg K, Reuter M, Martin B, Wells J, Claverys JP: Interconnection of competence, stress and CiaR regulons in Streptococcus pneumoniae: competence triggers stationary phase autolysis of ciaR mutant cells. Mol Microbiol 2004;51:1071-1086.
13.
Ulijasz AT, Andes DR, Glasner JD, Weisblum B: Regulation of iron transport in Streptococcus pneumoniae by RitR, an orphan response regulator. J Bacteriol 2004;186:8123-8136.
14.
Kloosterman TG, van der Kooi-Pol MM, Bijlsma JJ, Kuipers OP: The novel transcriptional regulator SczA mediates protection against Zn2+ stress by activation of the Zn2+-resistance gene czcD in Streptococcus pneumoniae. Mol Microbiol 2007;65:1049-1063.
15.
Rosch JW, Gao G, Ridout G, Wang YD, Tuomanen EI: Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniae. Mol Microbiol 2009;72:12-25.
16.
Song XM, Connor W, Hokamp K, Babiuk LA, Potter AA: Streptococcus pneumoniae early response genes to human lung epithelial cells. BMC Res Notes 2008;1:64.
17.
Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, Tuomanen EI: Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun 2004;72:5582-5596.
18.
Song XM, Connor W, Hokamp K, Babiuk LA, Potter AA: Transcriptome studies on Streptococcus pneumoniae, illustration of early response genes to THP-1 human macrophages. Genomics 2009;93:72-82.
19.
Rosch JW, Mann B, Thornton J, Sublett J, Tuomanen E: Convergence of regulatory networks on the pilus locus of Streptococcus pneumoniae. Infect Immun 2008;76:3187-3196.
20.
Williamson YM, Gowrisankar R, Longo DL, Facklam R, Gipson IK, Ades EP, Carlone GM, Sampson JS: Adherence of nontypeable Streptococcus pneumoniae to human conjunctival epithelial cells. Microb Pathog 2008;44:175-185.
21.
Molzen TE, Burghout P, Bootsma HJ, Brandt CT, van der Gaast-de Jongh CE, Eleveld MJ, Verbeek MM, Frimodt-Moller N, Ostergaard C, Hermans PW: Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun 2011;79:288-297.
22.
Rogers PD, Thornton J, Barker KS, McDaniel DO, Sacks GS, Swiatlo E, McDaniel LS: Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun 2003;71:2087-2094.
23.
Bootsma HJ, Egmont-Petersen M, Hermans PW: Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: evidence for a distinct response to encapsulated strains. Infect Immun 2007;75:5489-5499.
24.
Joyce EA, Popper SJ, Falkow S: Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression. BMC Genomics 2009;10:404.
25.
Banerjee A, Van Sorge NM, Sheen TR, Uchiyama S, Mitchell TJ, Doran KS: Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cell Microbiol 2010;12:1576-1588.
26.
Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR: Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989;77:51-59.
27.
Callegan MC, Booth MC, Jett BD, Gilmore MS: Pathogenesis of Gram-positive bacterial endophthalmitis. Infect Immun 1999;67:3348-3356.
28.
Manco S, Hernon F, Yesilkaya H, Paton JC, Andrew PW, Kadioglu A: Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect Immun 2006;74:4014-4020.
29.
Sanders ME, Norcross EW, Moore QC 3rd, Fratkin J, Thompson H, Marquart ME: Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis. J Ocul Pharmacol Ther 2010;26:571-577.
30.
Ernst JD, Decazes JM, Sande MA: Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun 1983;41:275-279.
31.
Wood WB Jr, Smith MR, Watson B: Surface phagocytosis - its relation to the mechanism of recovery in pneumococcal pneumonia. Science 1946;104:28-29.
32.
Weiser JN, Austrian R, Sreenivasan PK, Masure HR: Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994;62:2582-2589.
33.
Marion C, Burnaugh AM, Woodiga SA, King SJ: Sialic acid transport contributes to pneumococcal colonization. Infect Immun 2011;79:1262-1269.
34.
King SJ, Hippe KR, Weiser JN: Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol Microbiol 2006;59:961-974.
35.
Sanders ME, Norcross EW, Moore QC, Onwubiko C, King LB, Fratkin J, Marquart ME: A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model. Clin Ophthalmol 2008;2:793-800.
36.
Davey P, Barza M, Peckman C: Spontaneous inhibition of bacterial growth in experimental Gram-negative endophthalmitis. Invest Ophthalmol Vis Sci 1987;28:867-873.
37.
Rimini R, Jansson B, Feger G, Roberts TC, de Francesco M, Gozzi A, Faggioni F, Domenici E, Wallace DM, Frandsen N, Polissi A: Global analysis of transcription kinetics during competence development in Streptococcus pneumoniae using high density DNA arrays. Mol Microbiol 2000;36:1279-1292.
38.
Hava DL, Hemsley CJ, Camilli A: Transcriptional regulation in the Streptococcus pneumoniae rlrA pathogenicity islet by RlrA. J Bacteriol 2003;185:413-421.
39.
LeMieux J, Hava DL, Basset A, Camilli A: RrgA and RrgB are components of a multisubunit pilus encoded by the Streptococcus pneumoniae rlrA pathogenicity islet. Infect Immun 2006;74:2453-2456.
40.
LeMieux J, Woody S, Camilli A: Roles of the sortases of Streptococcus pneumoniae in assembly of the RlrA pilus. J Bacteriol 2008;190:6002-6013.
41.
Hava DL, Camilli A: Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 2002;45:1389-1406.
42.
Gohar M, Okstad OA, Gilois N, Sanchis V, Kolsto AB, Lereclus D: Two-dimensional electrophoresis analysis of the extracellular proteome of Bacillus cereus reveals the importance of the PlcR regulon. Proteomics 2002;2:784-791.
43.
Gominet M, Slamti L, Gilois N, Rose M, Lereclus D: Oligopeptide permease is required for expression of the Bacillus thuringiensis plcR regulon and for virulence. Mol Microbiol 2001;40:963-975.
44.
Fagerlund A, Brillard J, Furst R, Guinebretiere MH, Granum PE: Toxin production in a rare and genetically remote cluster of strains of the Bacillus cereus group. BMC Microbiol 2007;7:43.
45.
Gohar M, Faegri K, Perchat S, Ravnum S, Okstad OA, Gominet M, Kolsto AB, Lereclus D: The PlcR virulence regulon of Bacillus cereus. PLoS One 2008;3:e2793.
46.
Brown JS, Gilliland SM, Holden DW: A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence. Mol Microbiol 2001;40:572-585.
47.
Loisel E, Jacquamet L, Serre L, Bauvois C, Ferrer JL, Vernet T, Di Guilmi AM, Durmort C: AdcAII, a new pneumococcal Zn-binding protein homologous with ABC transporters: biochemical and structural analysis. J Mol Biol 2008;381:594-606.
48.
Loisel E, Chimalapati S, Bougault C, Imberty A, Gallet B, Di Guilmi AM, Brown J, Vernet T, Durmort C: Biochemical characterization of the histidine triad protein PhtD as a cell surface zinc-binding protein of pneumococcus. Biochemistry 2011;50:3551-3558.
49.
Bayle L, Chimalapati S, Schoehn G, Brown J, Vernet T, Durmort C: Zinc uptake by Streptococcus pneumoniae depends on both AdcA and AdcAII and is essential for normal bacterial morphology and virulence. Mol Microbiol 2011;82:904-916.
50.
Bersch B, Bougault C, Roux L, Favier A, Vernet T, Durmort C: New insights into histidine triad proteins: solution structure of a Streptococcus pneumoniae PhtD domain and zinc transfer to AdcAII. PLoS One 2013;8:e81168.
51.
Plumptre CD, Eijkelkamp BA, Morey JR, Behr F, Counago RM, Ogunniyi AD, Kobe B, O'Mara ML, Paton JC, McDevitt CA: AdcA and AdcAII employ distinct zinc acquisition mechanisms and contribute additively to zinc homeostasis in Streptococcus pneumoniae. Mol Microbiol 2014;91:834-851.
52.
Plumptre CD, Hughes CE, Harvey RM, Eijkelkamp BA, McDevitt CA, Paton JC: Overlapping functionality of the Pht proteins in zinc homeostasis of Streptococcus pneumoniae. Infect Immun 2014;82:4315-4324.
53.
Adamou JE, Heinrichs JH, Erwin AL, Walsh W, Gayle T, Dormitzer M, Dagan R, Brewah YA, Barren P, Lathigra R, Langermann S, Koenig S, Johnson S: Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun 2001;69:949-958.
54.
Spellerberg B, Cundell DR, Sandros J, Pearce BJ, Idanpaan-Heikkila I, Rosenow C, Masure HR: Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol Microbiol 1996;19:803-813.
55.
Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, Durkin AS, Gwinn M, Kolonay JF, Nelson WC, Peterson JD, Umayam LA, White O, Salzberg SL, Lewis MR, Radune D, Holtzapple E, Khouri H, Wolf AM, Utterback TR, Hansen CL, McDonald LA, Feldblyum TV, Angiuoli S, Dickinson T, Hickey EK, Holt IE, Loftus BJ, Yang F, Smith HO, et al: Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 2001;293:498-506.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.